ASHR Stock Recent News
ASHR LATEST HEADLINES
Investors are paying close attention to China, Japan, and India ETFs lately, according to VettaFi's Explorer data and analytics tool. Interest in non-U.S. economies is high as investors look for more ways to diversify their portfolios.
Exchange-traded funds that target Chinese stocks were falling Monday, after China reported disappointing growth for the second quarter, bringing the ETFs deeper into the red so far this year.
China's central bank tries new stimulus efforts to boost slowing growth. Why unemployment is proving to be key to China's economic troubles.
China recently lowered its short-term borrowing rates, take a look into how China ETFs are affected.
What does the impact of strained relations between China and the West mean for global trade? Why China's recovery is starting to falter.
Chinese policymakers maintained a 'pro-growth' stance at last week's Politburo meeting, building on the Q1 GDP momentum. Having cooled in the last few months, Chinese equities could still benefit from the second leg of the post-reopening recovery.
China's stronger-than-expected growth bodes well for many EMs – but does it also mean additional inflation risks down the toad? Even though the IMF spring meetings eased concerns about a recession in advanced economies, both the U.S. and the Eurozone are expected to expand by about 1% or so this year in real terms.
Exchange-traded funds that buy Chinese stocks were trading down Monday after China announced at its annual legislative session over the weekend a growth target near the low end of market expectations.
Chinese stocks are matriculating higher to start 2023, benefiting scores of US-listed exchange traded funds in the process. Up 8.24% year-to-date, the Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR) is certainly part of that group.
As hoped, looser COVID-19 restrictions have boosted service sector activity in mainland China, adding to hopes that resurgent economic growth will be seen in early 2023 and fueling speculation of diminished global recession risks. Companies widely cited the additional freedoms created by the unwinding of COVID-19 health restrictions as having boosted business levels, driving in particular a resurgence in new business inflows after four months of continual decline, which had been blamed primarily on the Omicron outbreak.